We are offering Discovery Alliances with pharmaceutical and biotechnological companies interested in developing macrocycles in their therapeutic area of interest and with Drug Discovery CROs for:

  • Synthesis of small focussed macrocycle libraries;
  • Hit-to-lead, rational design from linear peptide and other starting points;
  • Address targets currently being exploited by biologics, but through oral delivery;
  • Access to intracellular targets;
  • Paratope mimicking;
  • Scale-up